Health ❯ Healthcare ❯ Women's Health

Menopause

Hormone Replacement Therapy Hormone Therapy Perimenopause Treatment Options Hormonal Treatments Menopause Clinics Vasomotor Symptoms Hormone Therapy Risks Non-Hormonal Treatments Hot Flashes Estrogen Therapy Legislation Perimenopause Care Menopause Symptoms Menopausal Hormone Therapy Menopause Care Equity Act Symptoms Management Health Legislation Pregnancy Surgical Options Vaginal Bleeding Insurance Coverage Access to Care Long-term Health Benefits Endometriosis FDA Regulations Osteoporosis Treatment Health Outcomes Patient Counseling Menopausal Symptoms Chronic Diseases Patient Autonomy Symptoms Expert Opinions Risks and Benefits Postmenopausal Issues Breast Cancer Risk Osteoporosis Risk Premenopausal Women Bladder Control Menstrual Problems Access to Treatment Menopause Treatment Mental Health Workplace Support Education Nutritional Strategies Personal Nutrition Legislative Impact Menopause Treatments Health Care Legislation NHS Health Checks Commercialization

NICE Recommends Fezolinetant for NHS Use in England to Treat Menopausal Hot Flushes and Night Sweats

NICE says the once-daily non‑hormonal pill offers a cost‑effective option for people who cannot use HRT.

Halle Berry Says Newsom Never Reached Out; Governor Unveils Budget Plan to Expand Menopause Care

NHS England Names Nine Conditions for NHS Online Launch in 2027

FDA Expands Addyi Use to Postmenopausal Women Under 65

FDA Lifts Broad Black-Box Warnings From Many Menopause Hormone Therapies

Study Finds No Added Breast Cancer Risk From Menopausal Hormone Therapy in BRCA Carriers

Newsom Says Menopause Care Funding Is In Next California Budget After Halle Berry’s Rebuke

FDA Drops Broad Black-Box Warnings on Menopause Hormone Therapy

FDA Removes Broad Boxed Warnings From Many Menopause Hormone Therapies

FDA to Remove Most Boxed Warnings From Menopause Hormone Therapies

FDA Approves Lynkuet, a Nonhormonal Pill for Menopausal Hot Flashes

Hims & Hers Launches Menopause Care on Hers Platform as Shares Spike

FDA Signals Possible Revisions to Menopause Hormone Therapy Black Box Warning

Amazon's One Medical Launches Nationwide Perimenopause and Menopause Visits

Oura Lines Up $875 Million Series E at $10.9 Billion Valuation, Secures $250 Million Credit Line

Estradiol Therapy Route Tied to Different Memory Skills After Menopause, Study Finds

Danish Study Finds No Link Between Vaginal Estrogen Tablets and Recurrent Ischemic Stroke

BMJ Experts Warn Against Commercial Menopause Testing and Compounded Hormones

FDA Begins Expert Review of Menopause Hormone Therapy Warnings